Project Grant R43GM131542

This $788,406 project grant from the National Institutes of Health National Institute of Allergy and Infectious Diseases, under the Allergy and Infectious Diseases Research program (CFDA 93.855), will fund the development of a sensitive, direct reading bioaerosol detection platform to quantify airborne pathogens such as SARS-CoV-2. Aerosol Devices Inc. will integrate their gentle condensation-growth capture sampler, which concentrates intact, viable virus particles into a small liquid volume...

This Project Grant award from the National Science Foundation's (NSF) Biological Sciences program (CFDA 47.074) provides $335,268 to the University of Texas at Austin to investigate the evolutionary conservation of a group of viral proteins that help viruses evade the immune systems of a wide range of animals, including birds, reptiles, and insects. The research aims to uncover whether viruses have used similar immune evasion tactics for millions of years, even before humans existed. The...

The National Institute of Allergy and Infectious Diseases (NIAID) has awarded Colorado State University a $340,408 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to develop and validate an assay for precision antiretroviral therapy to combat drug resistance in HIV patients. The key products and services to be delivered under this award include: Improving the throughput and capacity of an existing infectivity assay using proviral constructs with an H2B-mRFP...

The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $416,625 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Nevada, Las Vegas (UNLV) for the "Genomic Surveillance of Mpox Through the Development of a Wastewater Intelligence Model and Data Analytics Platform" project. The goal of this high-risk, high-reward proposal is to leverage UNLV's previous successful approaches in wastewater surveillance for...

The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $776,341 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Illinois on September 16, 2025. The purpose of this grant is to develop a microfluidic cartridge, molecular biology method, biosensor, and detection instrument that can simultaneously detect HIV, hepatitis B virus (HBV), and hepatitis C virus (HCV) viral loads from a minimal 100 μL whole blood sample. This...

This Project Grant from the National Science Foundation's Engineering Directorate (NSF ENG) provides $249,829 to Northeastern University to develop an integrated platform for high accuracy measurements of viral particle count and infectious titer. The platform will combine nano-pore technology to identify viral particles based on biophysical properties with single-molecule RNA fluorescence in situ hybridization to discriminate individual molecules of viral RNA in infected cells. This will enable...

The National Institutes of Health (NIH) awarded a $4,399,999.00 Cooperative Agreement under the Trans-NIH Research Support program (CFDA 93.310) to The Leland Stanford Junior University (Stanford University) to comprehensively identify and characterize the human-associated virome. The VAST (Viromes Across Spaces and Time) Center at Stanford University will employ innovative approaches to study longitudinal samples from several unique cohorts, including individuals tracked for up to 13.5 years,...

This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855), provides $429,000 from August 1, 2025 to July 31, 2027 to researchers at the University of Texas at Dallas (UTD). The project aims to develop innovative methods for measuring the distribution and viability of viruses in bioaerosols, focusing on sub-5mm and submicron particles that can transmit long distances....

This three-year, $502,187 project grant from the National Science Foundation's Division of Emerging Frontiers will support the discovery and characterization of novel viral pathogens of Caenorhabditis elegans. Funded under the Biological Sciences program (CFDA 47.074), the award aims to identify new viruses in wild-caught free-living nematodes that can infect C. elegans. West Chester University of Pennsylvania will conduct the work, with support provided to the Commonwealth of Pennsylvania....

The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $181,892 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Children's Hospital Corporation (doing business as Boston Children's Hospital) for the project "Metagenomic Profiling of Dust Samples for School-Based Viral Surveillance." The project aims to validate the use of viral metagenomic sequencing of dust samples from elementary school classrooms to detect emerging...